23andMe

Billionaire VC Tim Draper (via Draper Associates) has led a $6 million Series A in wellness tracking startup, Vivoo. Also participating in the funding round is ONCE Ventures, Revo Capital, 500 Startup

Now that you have that COVID dog, Embark Veterinary wants to help him or her be in your life for a long time by offering DNA testing with the goal of increasing their lifespan.

Maryland and Montana have become the first U.S. states to pass laws that make it tougher for law enforcement to access DNA databases. The new laws, which aim to safeguard the genetic privacy of millio

Consumer genomics company Ancestry has confirmed it fought two U.S. law enforcement requests to access its DNA database in the past six months, but that neither request resulted in turning over custom

Genetics testing and genome research company 23andMe is set to go public via a merger with special purpose acquisition company (SPAC) VG Acquisition Corp., a vehicle set up by Richard Branson and his

DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding, confirme

Over the past 12 months, Maven, the benefits provider focused on women’s health and family planning, has expanded its customer base to include more than 100 companies, and grown its telehealth s

A state senator in California is introducing legislation designed to provide more oversight over direct-to-consumer genetic testing companies. The new regulations, introduced by Santa Ana’s Demo

Excitement in the consumer genetic testing market continues to show signs of slowing down. In the past two weeks, layoffs have hit two of the biggest consumer genetic testing services — 23andme and

Are January layoffs just a few post-WeWork jitters? TechCrunch has found itself writing about layoffs at a few notable tech companies this week — and not just SoftBank-backed ones. The focus is very

Layoffs in the technology and venture-backed worlds continued today, as 23andMe confirmed to CNBC that it laid off around 100 people, or about 14% of its formerly 700-person staff. The cuts would be n

Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with

All of that genetic material that 23andMe has been collecting is finally being used for commercial drug development — specifically dermatological drugs. The company inked an agreement with Spani

With 12 offices and 350 employees around the world, 3Q Digital is a giant among growth marketing agencies. They’ve worked with companies like Brandless, Opendoor, and Warby Parker, but they also hav

Healthtech is apparently in a golden age. Just a few weeks ago, Livongo and Health Catalyst raised a combined $500 million through IPOs with a joint valuation reaching $3.5 billion...

Why is tech still aiming for the healthcare industry? It seems full of endless regulatory hurdles or stories of misguided founders with no knowledge of the space, running headlong into it, only to fal

In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate research into a new field of medicine examining the connections between the millions of bacteria livi

Venture capitalists are pouring hundreds of millions of dollars into healthcare startups pitching lower-cost alternatives to traditional services, and one of their primary targets is diagnostics. As i

The seven Africa-focused companies that presented as part of Y Combinator’s Winter 2019 class of 200 startups may seem like a small percentage for such a large class, but it represents the growi

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar wi